PulsePoint, a health-focused technology company and division of Internet Brands, is seeking to reshape pharma media strategy by expanding programmatic access to electronic health records (EHRs) across major U.S. hospital and health systems.
The company says this move gives life science brands the ability to reach more than 700,000 prescribers across both ambulatory and inpatient settings, with the goal of influencing clinical decisions at the point of care.
PulsePoint hopes that by integrating brand messaging directly into the EHR workflow—spanning acute, specialty, and chronic care environments—it can help pharmaceutical advertisers increase awareness and drive measurable script lift.
The company is aiming to differentiate itself by offering seamless EHR integration alongside other digital channels. As outlined in the release, brands can “unify their EHR buys with other channels and media into a single cohesive omnichannel buy, with advanced HCP targeting, frequency controls and synchronized messaging across 100% of HCPs reached.”
PulsePoint shared that early results appear promising. A four-month campaign targeting primary care physicians and nephrologists through the EHR reportedly showed that “exposed HCPs wrote 86% more TRx of the client’s brand compared to the average prescriber in the US.”
Tech companies across healthcare marketing are increasingly focused on integrating every element of the omnichannel media mix—and point-of-care (POC) and EHR environments are emerging as some of the most critical components. PulsePoint’s move is in step with this broader industry trend: a push toward unifying engagement across channels and connecting with HCPs during meaningful clinical moments. It’s a strategic expansion that doesn’t just reflect where the market is going—it helps push the entire pharma media ecosystem forward.
To read the full press release click here.